3.2. Preparation of Starting Materials
3.2.1. Synthesis of Starting 4-Chloro-2-iodo-5-methylaniline (28j)
4-Chloro-2-iodo-5-methylaniline (
28j): This compound was synthesized using a procedure originally reported for the modification of 4-chloroaniline [
37]. A suspension of 4-chloro-3-methylaniline (141 mg, 1.00 mmol) in water (3 mL) and toluene (0.3 mL) magnetically stirred at 18 °C was treated with NaHCO
3 (134 mg, 1.60 mmol) and iodine (203 mg, 0.80 mmol) over a period of 0.5 h. The reaction mixture was then poured into water (15 mL). The aqueous layer was extracted with ethyl acetate (2 × 10 mL), and the combined organic phases were washed with Na
2S
2O
3 (2 × 5 mL of a 5% aqueous solution) and brine (1 × 5 mL), then dried (Na
2SO
4), and concentrated under reduced pressure. The resulting yellow oil was subjected to flash chromatography (EtOAc/hexane, 1:8,
v/
v). The titled compound was obtained as light-brown crystals, m.p. 56–58 °C (Hexane), lit [
38] m.p. 65 °C, R
f 0.80 (EtOAc/hexane, 1:4,
v/
v). Yield of 240 mg (0.90 mmol, 90%).
1H NMR (400 MHz, CDCl
3) δ 7.47 (s, 1H), 6.75 (s, 1H), 3.99 (br. s, 2H), 2.21 (s, 3H);
13C{
1H} NMR (101 MHz, CDCl
3) δ 145.8, 140.2, 135.3, 127.5, 114.8, 81.6, 18.7; FTIR,
vmax: 3420, 3347, 2920, 2728, 1703, 1487, 1447, 1384, 1369, 1296, 1258, 1194, 1054 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
7H
8ClIN [M+H]
+: 267.9385, found: 267.9387 (−0.8 ppm).
3.2.2. Synthesis of Starting Indole (14j)
5-Chloro-6-methyl-2-pentyl-1
H-indole (
14j): This compound was prepared using a modified method, previously shown in the literature [
39]. A suspension of 4-chloro-2-iodo-5-methylaniline (
28j; 803 mg, 3.00 mmol), PdCl
2(PPh
3)
2 (42.0 mg, 0.06 mmol, 2.0 mol%), and CuI (6.0 mg, 0.03 mmol, 1.0 mol%) in 15.0 mL triethylamine was degassed with argon and evacuated/backfilled with argon (3 cycles). The reaction mixture was stirred at 30 °C for 10 min. After the addition of the alkyne (3.6 mmol), the suspension was stirred for 24 h at 30 °C under argon atmosphere (progress of reaction monitored using TLC). The removal of the solvent was performed under reduced pressure, and the residue was used in next stage without purification. To the crude material, we added 10 mol. % (57 mg) CuI and 15 mL of DMF, and the mixture was kept at reflux under nitrogen for 10 h and then concentrated to dryness. The residue was taken up in ethyl acetate and filtered through Celite. The titled compound was purified using column chromatography (EtOAc/hexane, 1:6,
v/
v). The titled compound was obtained as colorless crystals, m.p. 91–92 °C, R
f 0.69 (EtOAc/hexane, 1:3,
v/
v). Yield of 601 mg (2.55 mmol, 85%).
1H NMR (400 MHz, CDCl
3) δ 7.76 (s, 1H), 7.34 (s, 1H), 7.29 (s, 1H), 6.13 (s, 1H), 2.71 (t,
J = 7.6 Hz, 2H), 2.42 (s, 3H), 1.74–1.67 (m, 2H), 1.38–1.33 (m, 4H), 0.92–0.88 (m, 3H);
13C{
1H} NMR (101 MHz, CDCl
3) δ 141.0, 134.9, 128.0, 127.5, 126.9, 121.0, 110.6, 99.1, 31.6, 28.9, 28.4, 22.6, 20.4, 14.1; FTIR,
vmax: 3394, 2950, 1734, 1679, 1635, 1555, 1520, 1505, 1472, 1459, 1376, 1298 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
14H
17ClN [M-H]
−: 234.1055, found: 234.1059 (−1.6 ppm).
3.2.3. Synthesis of Starting 1H-indole-3-carbaldehydes (29)
5-Fluoro-2-methyl-1
H-indole-3-carbaldehyde (
29b), Typical Procedure C for preparation of 1
H-indole-3-carboxaldehydes (
29): The procedure was adapted from the previously described synthetic protocol [
40]. POCl
3 (0.35 mL, 3.7 mmol) was added dropwise into stirred and ice-cooled DMF (1.0 mL). The reaction mixture was stirred at 1–5 °C for 20 min; then, a solution of 5-fluoro-2-methyl-1
H-indole (
14b) (462 mg, 3.10 mmol) in DMF (1.0 mL) was slowly added. The resulting reaction mixture was slowly warmed to 35 °C and kept at this temperature for 40 min. It was then allowed to cool down to room temperature. To this mixture, ice (~10 g) was added, followed by 5 M NaOH solution (6 mL, 31.00 mmol). The reaction mixture was heated at 95 °C for 30 min; then, it was allowed to cool down to room temperature. To this mixture, ice (~10 g) was again added, and the resulting reaction mixture was stirred for 30 min. The desired product was collected by filtrating it and washed several times with water. The titled compound was purified using column chromatography (EtOAc/hexane, 1:2,
v/
v). The titled compound was obtained as colorless solid, m.p. 217.6–219.9 °C (EtOAc), lit [
40]. m.p. 176–173 °C, R
f 0.64 (EtOAc/hexane, 1:1). Yield of 472 mg (2.67 mmol, 86%).
1H NMR (400 MHz, DMSO-
d6) δ 12.11 (br. s, 1H), 10.02 (s, 1H), 7.71 (dt,
J = 9.8, 1.8 Hz, 1H), 7.39 (ddd,
J = 8.7, 4.5, 1.2 Hz, 1H), 7.06–6.97 (m, 1H), 2.67 (s, 3H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 184.4, 158.7 (d,
J = 234.7 Hz), 150.0, 132.0, 126.3 (d,
J = 11.0 Hz), 113.8 (d,
J = 4.3 Hz), 112.6 (d,
J = 9.9 Hz), 110.5 (d,
J = 25.7 Hz), 105.1 (d,
J = 24.4 Hz), 11.6;
19F NMR (376 MHz, DMSO-
d6) δ −121.59; FTIR,
vmax: 3265, 1620, 1585, 1481, 1454, 1383, 1255, 1189, 1176, 1121, 1099 cm
−1; HRMS (ESI TOF)
m/
z: calc’d for C
10H
8FNNaO [M+Na]
+: 200.0482, found 200.0486 (−2.0 ppm).
5-Isopropyl-2-methyl-1H-indole-3-carbaldehyde (29d): This compound was prepared using Typical Procedure C employing 2-methyl-5-isopropyl-1H-indole (14d) (536 mg, 3.10 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:2, v/v). The titled compound was obtained as colorless solid, m.p. 182.4–183.7 °C (EtOH), Rf 0.37 (EtOAc/hexane, 1:1). Yield 554 mg (2.76 mmol, 89%). 1H NMR (400 MHz, DMSO-d6) δ 11.88 (s, 1H), 10.02 (s, 1H), 7.90 (s, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.06 (d, J = 8.3 Hz, 1H), 3.04–2.89 (m, 1H), 2.66 (s, 3H), 1.24 (s, 3H), 1.22 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 184.2, 148.6, 142.2, 133.9, 125.8, 121.6, 117.1, 113.6, 111.1, 33.7, 24.6 (2C), 11.5; FTIR, vmax: 3278, 2960, 1635, 1622, 1584, 1479, 1459, 1373, 1245, 1202 cm−1; HRMS (ESI TOF) m/z: calc’d for C13H15NNaO [M+Na]+: 224.1046, found 224.1040 (2.7 ppm).
2,5,6-Trimethyl-1H-indole-3-carbaldehyde (29e): This compound was prepared using Typical Procedure C employing 2,5,6-trimethyl-1H-indole (14e) (493 mg, 3.10 mmol), The titled compound was purified using column chromatography (EtOAc/hexane, 1:3, v/v). The titled compound was obtained as colorless solid, m.p. 263.5–265.5 °C (EtOH), Rf 0.24 (EtOAc/hexane, 1:1, v/v). Yield 510 mg (2.72.00 mmol, 88%). 1H NMR (400 MHz, DMSO-d6) δ 11.75 (s, 1H), 9.98 (s, 1H), 7.80 (s, 1H), 7.14 (s, 1H), 2.64 (s, 3H), 2.28 (s, 6H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 183.9, 147.8, 134.2, 131.1, 130.1, 123.9, 120.4, 113.4, 111.7, 20.1, 19.9, 11.5; FTIR, vmax: 3209, 2922, 1618, 1467, 1370, 1272, 1183, 1085 cm−1; HRMS (ESI TOF) m/z: calc’d for C12H13NNaO [M+Na]+: 210.0889, found 210.0888 (0.8 ppm).
2,6,7-Trimethyl-1H-indole-3-carbaldehyde (29f): This compound was prepared using Typical Procedure C employing 2,6,7-trimethyl-1H-indole (14f) (493 mg, 3.10 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:3, v/v). The titled compound was obtained as colorless solid, m.p. 239.4–240.3 °C (EtOH), Rf 0.25 (EtOAc/hexane, 1:2). Yield 499 mg (2.67 mmol, 86%) 1H NMR (400 MHz, DMSO-d6) δ 11.95 (s, 1H), 10.13 (s, 1H), 7.10 (d, J = 8.1 Hz, 1H), 6.98 (d, J = 8.1 Hz, 1H), 2.66 (s, 3H), 2.65 (s, 3H), 2.30 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 184.4, 148.6, 134.4, 129.1, 128.2, 125.7, 125.0, 114.6, 108.8, 20.0, 18.3, 13.2; FTIR, vmax: 3086, 2863, 1614, 1486, 1439, 1379, 1292, 1141, 1053 cm−1; HRMS (ESI TOF) m/z: calc’d for C12H13NNaO [M+Na]+: 210.0889, found 210.0888 (0.7 ppm).
2-Pentyl-1H-indole-3-carbaldehyde (29h): This compound was prepared using Typical Procedure C employing 2-pentyl-1H-indole (14h) (580 mg, 3.10 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as colorless solid, m.p. 119–120 °C, Rf 0.38 (EtOAc/hexane, 1:3, v/v). Yield 660 mg (3.07 mmol, 99%). 1H NMR (400 MHz, CDCl3) δ 10.19 (s, 1H), 9.75 (s, 1H), 8.33–8.24 (m, 1H), 7.42–7.37 (m, 1H), 7.29–7.24 (m, 2H), 3.10 (t, J = 7.7 Hz, 2H), 1.80 (q, J = 7.4 Hz, 2H), 1.39–1.31 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 184.8, 152.8, 135.5, 126.1, 123.6, 122.9, 121.1, 114.4, 111.3, 31.5, 30.0, 26.5, 22.5, 14.0; FTIR, vmax: 3182, 2937, 2864, 1927, 1683, 1618, 1577, 1454, 1371, 1225 cm−1; HRMS (ESI TOF) m/z calc’d. for C14H17NNaO [M+Na]+: 238.1202, found: 238.1201 (0.7 ppm).
5-Chloro-6-methyl-2-pentyl-1H-indole-3-carbaldehyde (29j): This compound was prepared using Typical Procedure C employing 5-chloro-6-methyl-2-pentyl-1H-indole (14j) (729 mg, 3.10 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as colorless solid, m.p. 210–212 °C, Rf 0.46 (EtOAc/hexane, 1:3, v/v). Yield of 774 mg (2.95 mmol, 95%). 1H NMR (400 MHz, DMSO-d6) δ 11.95 (br. s, 1H), 10.02 (s, 1H), 7.99 (s, 1H), 7.43 (s, 1H), 3.03 (t, J = 7.4 Hz, 2H), 2.38 (s, 3H), 1.75–1.65 (m, 2H), 1.33–1.24 (m, 4H), 0.84 (t, J = 6.3 Hz, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 184.2, 153.6, 134.6, 128.6, 128.0, 124.7, 121.8, 113.0, 111.6, 30., 29.4, 25.4, 21.9, 20.1, 13.9; FTIR, vmax: 3092, 2808, 1922, 1734, 1681, 1656, 1623, 1558, 1505, 1454, 1373, 1237 cm−1; HRMS (ESI TOF) m/z calc’d. for C15H18ClNNaO [M+Na]+: 286.0969, found: 286.0969 (0.1 ppm).
3.2.4. Synthesis of Starting 3-(2-nitrovinyl)-1H-indoles (10)
(E)-5-Fluoro-2-methyl-3-(2-nitrovinyl)-1H-indole (10ba), Typical Procedure D for preparation of 3-(2-nitrovinyl)-1H-indoles (10): Solid ammonium acetate (93 mg, 1.20 mmol) was added to a suspension of 5-fluoro-2-methyl- 1H-indole-3-carbaldehyde (29b) (354 mg, 2.00 mmol) in nitromethane (1 mL). The mixture was vigorously stirred at reflux for 6 h. Then, the mixture was cooled in an ice bath, and the solid that appeared was filtered and purified using column chromatography (EtOAc/hexane, 1:2, v/v). The titled compound was obtained as red solid, m.p. 214.9–216.5 °C (EtOH), Rf 0.83 (EtOAc/hexane, 1:1). Yield of 405 mg (1.84 mmol, 92%). 1H NMR (400 MHz, DMSO-d6) δ 12.32 (br. s, 1H), 8.27 (d, J = 13.2 Hz, 1H), 7.93 (d, J = 13.3 Hz, 1H), 7.72 (dd, J = 10.2, 2.5 Hz, 1H), 7.40 (dd, J = 8.8, 4.6 Hz, 1H), 7.04 (td, J = 9.1, 2.4 Hz, 1H), 2.59 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 158.7 (d, J = 234.8 Hz), 149.0 (2C), 133.0, 130.3, 125.9 (d, J = 10.5 Hz), 113.0 (d, J = 9.9 Hz), 110.6 (d, J = 25.6 Hz), 106.0 (d, J = 24.9 Hz), 105.3 (d, J = 4.0 Hz), 12.1; 19F NMR (376 MHz, DMSO-d6) δ -120.95; FTIR, vmax: 3275, 1603, 1466, 1310,1250, 1226, 1168cm−1; HRMS (ESI TOF) m/z: calc’d for C11H9FN2NaO2 [M+Na]+: 243.0540, found 243.0537 (1.5 ppm).
(E)-5-Isopropyl-2-methyl-3-(2-nitrovinyl)-1H-indole (10da): This compound was prepared using Typical Procedure D employing 2-methyl-5-isopropyl- 1H-indole-3-carbaldehyde (29d) (402 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:2, v/v). The titled compound was obtained as red solid, m.p. 225.3–227.0 °C (EtOH), Rf 0.51 (EtOAc/hexane, 1:1). Yield of 459 mg (1.88 mmol, 94%). 1H NMR (400 MHz, DMSO-d6) δ 12.17 (s, 1H), 8.30 (d, J = 13.1 Hz, 1H), 7.93 (d, J = 13.2 Hz, 1H), 7.64 (s, 1H), 7.32 (d, J = 8.3 Hz, 1H), 7.19–7.02 (m, 1H), 3.14–2.96 (m, 1H), 2.59 (s, 3H), 1.27 (s, 3H), 1.26 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 147.9, 142.6, 135.0, 133.5, 129.4, 125.5, 121.5, 117.7, 111.8, 105.3, 33.7, 24.6 (2C), 12.0; FTIR, vmax: 3199, 2960, 1598, 1580, 1476, 1299, 1272, 1237, 1183, 1096 cm−1; HRMS (ESI TOF) m/z: calc’d for C14H16N2NaO2 [M+Na]+: 267.1104, found 267.1101 (1.0 ppm).
(E)-2,5,6-Trimethyl-3-(2-nitrovinyl)-1H-indole (10ea): This compound was prepared using Typical Procedure D employing 2,5,6-trimethyl-1H-indole-3-carbaldehyde (29e) (374 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:2, v/v). The titled compound was obtained as red solid, m.p. 228.9–230.5 °C (EtOH), Rf 0.54 (EtOAc/hexane, 1:1). Yield of 419 mg (1.82.00 mmol, 91%) 1H NMR (400 MHz, DMSO-d6) δ 12.05 (s, 1H), 8.26 (d, J = 13.1 Hz, 1H), 7.90 (d, J = 13.0 Hz, 1H), 7.62 (s, 1H), 7.17 (s, 1H), 2.56 (s, 3H), 2.33 (s, 3H), 2.29 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 147.4, 135.3, 133.6, 131.6, 130.6, 129.0, 123.5, 120.6, 112.3, 105.2, 19.9, 19.7, 11.8; FTIR, vmax: 3273, 2918, 1743, 1598, 1572, 1476, 1298, 1226, 1171, 1077 cm−1; HRMS (ESI TOF) m/z: calc’d for C13H14N2NaO2 [M+Na]+: 253.0947, found 253.0942 (2.2 ppm).
(E)-2,6,7-Trimethyl-3-(2-nitrovinyl)-1H-indole (10fa): This compound was prepared using Typical Procedure D employing 2,6,7-trimethyl-1H-indole- 3-carbaldehyde (29f) (374 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as red solid, m.p. 219.8–221.0 °C (EtOH), Rf 0.25 (EtOAc/hexane, 1:2). Yield of 427 mg (1.86 mmol, 93%) 1H NMR (400 MHz, DMSO-d6) δ 12.14 (s, 1H), 8.77 (d, J = 13.2 Hz, 1H), 7.51 (d, J = 13.2 Hz, 1H), 7.13 (d, J = 8.1 Hz, 1H), 6.99 (d, J = 8.1 Hz, 1H), 2.58 (s, 3H), 2.55 (s, 3H), 2.34 (s, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 143.8, 135.7, 134.4, 130.7, 129.1, 127.1, 126.5, 125.1, 109.3, 105.4, 19.8, 16.3, 15.2; FTIR, vmax: 3209, 1602, 1584, 1461, 1421, 1185, 1041 cm−1; HRMS (ESI TOF) m/z: calc’d for C13H14N2Na1O2 [M+Na]+: 253.0947, found 253.0945 (1.0 ppm).
(E)-2-methyl-3-(2-nitrobut-1-en-1-yl)-1H-indole (10ac): This compound was prepared using Typical Procedure D employing 2-methyl-1H-indole-3- carbaldehyde (29a) (318 mg, 2.00 mmol) and nitropropane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as red solid, m.p. 134–138 °C, Rf 0.4 (EtOAc/hexane, 1:3, v/v). Yield of 345 mg (1.5 mmol, 75%). 1H NMR (400 MHz, CDCl3) δ 8.44 (s, 1H), 8.20 (s, 1H), 7.51 (d, J = 7.3 Hz, 1H), 7.36 (dd, J = 6.9, 1.5 Hz, 1H), 7.25–7.18 (m, 2H), 2.87 (q, J = 7.3 Hz, 2H), 2.51 (s, 3H), 1.23 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 150.2, 138.6, 135.8, 128.1, 126.3, 122.7, 121.2, 119.7, 111.2, 106.9, 22.2, 13.2, 12.5; FTIR, vmax: 3261, 2990, 1772, 1618, 1582, 1459, 1436, 1316, 1270, 1230 cm−1; HRMS (ESI TOF) m/z calc’d. for C13H14N2NaO2 [M+Na]+: 253.0947, found: 253.0950 (−0.8 ppm).
(
E)-3-(2-nitrovinyl)-2-ethyl-1
H-indole (
10ga): This compound was prepared using Typical Procedure D employing 2-ethyl-1
H-indole-3-carbaldehyde (
29g) [
40] (290 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4,
v/
v). The titled compound was obtained as yellow solid, m.p. 188–189 °C, R
f 0.35 (EtOAc/hexane, 1:3,
v/
v). Yield of 367 mg (1.7 mmol, 85%).
1H NMR (400 MHz, DMSO-
d6) δ 12.21 (s, 1H), 8.32 (d,
J = 13.2 Hz, 1H), 7.92 (d,
J = 13.2 Hz, 1H), 7.85 (dd,
J = 6.5, 1.9 Hz, 1H), 7.44 (dd,
J = 6.7, 1.8 Hz, 1H), 7.28–7.14 (m, 2H), 2.98 (q,
J = 7.6 Hz, 2H), 1.30 (t,
J = 7.6 Hz, 3H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 153.1, 136.7, 133.1, 129.9, 125.2, 123.1, 122.1, 120.5, 112.2, 104.3, 19.2, 14.3; FTIR,
vmax: 3224, 2911, 2903, 1624, 1588, 1556, 1434, 1266, 1159 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
12H
12N
2NaO
2 [M+Na]
+: 239.0791, found: 239.0788 (1.3 ppm).
(E)-3-(2-nitrovinyl)-2-pentyl-1H-indole (10ha): This compound was prepared using Typical Procedure D employing 2-pentyl-1H-indole- 3-carbaldehyde (29h) (430 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as colorless solid, m.p. 113–115 °C, Rf 0.4 (EtOAc/hexane, 1:3, v/v). Yield of 413 mg (1.60 mmol, 80%). 1H NMR (400 MHz, CDCl3) δ 9.05 (s, 1H), 8.37 (d, J = 13.2 Hz, 1H), 7.83 (d, J = 13.2 Hz, 1H), 7.74–7.64 (m, 1H), 7.48–7.38 (m, 1H), 7.32–7.26 (m, 2H), 2.96 (t, J = 7.7 Hz, 2H), 1.80–1.72 (m, 2H), 1.43–1.35 (m, 4H), 0.92 (t, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 150.0, 136.3, 133.3, 131.2, 125.6, 123.7, 122.7, 120.4, 111.9, 106.2, 31.5, 29.7, 26.6, 22.5, 14.0; FTIR, vmax: 3265, 2960, 2933, 1603, 1560, 1510, 1454, 1238, 1159 cm−1; HRMS (ESI TOF) m/z calc’d. for C15H18N2NaO2 [M+Na]+: 281.1260, found: 281.1252 (2.9 ppm).
(
E)-2-Benzyl-3-(2-nitrovinyl)-1
H-indole (
10ia): This compound was prepared using Typical Procedure D employing 2-benzyl-1
H-indole-3-carbaldehyde (
29i) [
40] (470 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4,
v/
v). The titled compound was obtained as red solid, m.p. 153.2–155.6 °C (EtOH), R
f 0.56 (EtOAc/hexane, 1:2). Yield of 470 mg (1.86 mmol, 93%)
1H NMR (400 MHz, DMSO-
d6) δ 12.34 (s, 1H), 8.43 (dd,
J = 13.2, 2.3 Hz, 1H), 7.95 (dd,
J = 13.2, 2.4 Hz, 1H), 7.90 (d,
J = 7.3 Hz, 1H), 7.48–7.41 (m, 1H), 7.36–7.20 (m, 7H), 4.39 (s, 2H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 149.2, 138.2, 136.7, 133.2, 130.6, 128.8 (2C), 128.4 (2C), 126.7, 125.1, 123.3, 122.1, 120.7, 112.3, 105.2, 31.6; FTIR,
vmax: 3237, 1614, 1576, 1478, 1461, 1298, 1274, 1244, 1226, 1171, 1097 cm
−1; HRMS (ESI TOF)
m/
z: calc’d for C
17H
14N
2NaO
2 [M+Na]
+: 301.0947, found 301.0941 (2.2 ppm).
(E)-5-chloro-6-methyl-3-(2-nitrovinyl)-2-pentyl-1H-indole (10ja): This compound was prepared using Typical Procedure D employing 5-chloro-6-methyl-2-pentyl-1H-indole-3-carbaldehyde (29j) (526 mg, 2.00 mmol) and nitromethane (1 mL). The titled compound was purified using column chromatography (EtOAc/hexane, 1:4, v/v). The titled compound was obtained as yellow solid, m.p. 169–171 °C, Rf 0.49 (EtOAc/hexane, 1:3, v/v). Yield of 490 mg (1.60 mmol, 80%). 1H NMR (400 MHz, CDCl3) δ 8.66 (s, 1H), 8.29 (d, J = 13.3 Hz, 1H), 7.77 (d, J = 13.3 Hz, 1H), 7.52 (s, 1H), 7.40 (s, 1H), 2.94 (t, J = 7.7 Hz, 2H), 2.50 (s, 3H), 1.79–1.69 (m, 2H), 1.43–1.34 (m, 4H), 0.92 (t, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 150.0, 135.1, 132.6, 131.7, 130.4, 130.2, 124.6, 121.8, 112.0, 105.7, 31.5, 29.6, 26.7, 22.5, 20.7, 14.1; FTIR, vmax: 3265, 2960, 2933, 1603, 1560, 1510, 1454, 1238, 1159 cm−1; HRMS (ESI TOF) m/z calc’d. for C16H19ClN2NaO2 [M+Na]+: 329.1027, found: 329.1032 (−1.5 ppm).
3.2.5. Preparation of N-Substituted 3-(2-nitrovinyl)-1H-indoles
(
E)-1-Benzyl-2-methyl-3-(2-nitrovinyl)-1
H-indole (
10la), Typical Procedure E for preparation of
N-substituted 3-(2-nitrovinyl)-1
H-indoles (
10): This method was developed in analogy to that described in the literature [
41]. To the solution of (
E)-2-methyl-3-(2-nitrovinyl)-1
H-indole (
10aa) (202 mg, 2.00 mmol) in DMF (2 mL), NaH (120 mg, 3.00 mmol, 60% in mineral oil) was added portionwise at 0 °C; then, the mixture was stirred for 30 min. The alkyl halide benzyl bromide (513 mg, 356 µL, 3.00 mmol) was added dropwise; then, the reaction mixture was allowed to warm to room temperature under constant stirring. The reaction progress was monitored using TLC. After completion of the reaction, water was added and extracted with EtOAc. The combined organic layer was washed with water and brine and then dried over anhydrous Na
2SO
4. The solvents were removed under reduced pressure to obtain the crude product, which was then purified using column chromatography (EtOAc/hexane, 1:6,
v/
v). The titled compound was obtained as yellow solid, m.p. 45–47 °C, lit [
42] m.p. 114–116 °C, R
f 0.6 (EtOAc/hexane, 1:3,
v/
v). Yield of 237 mg (0.81.00 mmol, 81%).
1H NMR (400 MHz, CDCl
3) δ 8.39 (d,
J = 13.3 Hz, 1H), 7.84 (d,
J = 13.2 Hz, 1H), 7.79–7.74 (m, 1H), 7.33–7.27 (m, 6H), 7.00 (dd,
J = 7.6, 1.9 Hz, 2H), 5.39 (s, 2H), 2.55 (s, 3H);
13C{
1H} NMR (101 MHz, CDCl
3) δ 146.1, 138.0, 136.4, 133.0, 131.6, 129.3 (2C), 128.1, 126.0 (2C), 125.4, 124.4, 122.9, 120.5, 110.6, 106.7, 47.4, 11.1; FTIR,
vmax: 3030, 2920, 1893, 1869, 1650, 1623, 1557, 1505, 1495, 1474, 1446, 1328 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
18H
16N
2NaO
2 [M+Na]
+: 315.1104, found: 315.1098 (2.0 ppm).
(E)-1-(Ethoxymethyl)-2-methyl-3-(2-nitrovinyl)-1H-indole (10ma): This compound was prepared using Typical Procedure E employing (E)-2-methyl-3-(2-nitrovinyl)-1H-indole (10aa) (404 mg, 2.00 mmol), (chloromethoxy)ethane (282 mg, 277 µL, 3.00 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:6, v/v). The titled compound was obtained as yellow solid, m.p. 79–81 °C, Rf 0.37 (EtOAc/hexane, 1:3, v/v). Yield of 380 mg (1.46 mmol, 73%). 1H NMR (400 MHz, CDCl3) δ 8.33 (d, J = 13.3 Hz, 1H), 7.77 (d, J = 13.3 Hz, 1H), 7.70–7.65 (m, 1H), 7.52–7.47 (m, 1H), 7.35–7.28 (m, 2H), 5.52 (s, 2H), 3.49 (q, J = 7.0 Hz, 2H), 2.63 (s, 3H), 1.18 (t, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 145.9, 138.0, 132.6, 132.1, 125.2, 123.7, 122.9, 120.2, 110.3, 107.1, 73.0, 64.5, 15.0, 10.8; FTIR, vmax: 2963, 2930, 2861, 1734, 1716, 1701, 1686, 1653, 1558, 1505, 1457, 1373, 1340, 1240 cm−1; HRMS (ESI TOF) m/z calc’d. for C14H16N2NaO3 [M+Na]+: 283.1053, found: 283.1059 (−1.9 ppm).
(E)-1,2-Dimethyl-3-(2-nitrobut-1-en-1-yl)-1H-indole (10kc): This compound was prepared using Typical Procedure E employing (E)-2-methyl-3-(2-nitrobut-1-en-1-yl)-1H-indole (10ac) (460 mg, 2.00 mmol), methyl iodide (426 mg, 187 µL, 3.00 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:6, v/v). The titled compound was obtained as yellow solid, m.p. 149–151 °C, Rf 0.43 (EtOAc/hexane, 1:3, v/v). Yield of 414 mg (1.7 mmol, 85%). 1H NMR (400 MHz, CDCl3) δ 8.23 (s, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.34 (d, J = 8.1 Hz, 1H), 7.27 (t, J = 7.4 Hz, 1H), 7.21 (t, J = 7.5 Hz, 1H), 3.74 (s, 3H), 2.86 (q, J = 7.2 Hz, 2H), 2.47 (s, 3H), 1.22 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 149.7, 140.4, 137.5, 128.5, 125.5, 122.3, 121.1, 119.7, 109.6, 106.2, 30.2, 22.2, 12.5, 11.7; FTIR, vmax: 3298, 3202, 2821, 1869, 1736, 1721, 1694, 1625, 1558, 1509, 1472, 1376, 1242 cm−1; HRMS (ESI TOF) m/z calc’d. for C14H16N2NaO2 [M+Na]+: 267.1104, found: 267.1111 (−2.7 ppm).
(E)-1-(Ethoxymethyl)-3-(2-nitrovinyl)-2-pentyl-1H-indole (10na): This compound was prepared using Typical Procedure E employing (E)-3-(2- nitrovinyl)-2-pentyl-1H-indole (10ha) (516 mg, 2.00 mmol), (chloromethoxy)ethane (282 mg, 277 µL, 3.00 mmol). The titled compound was purified using column chromatography (EtOAc/hexane, 1:6, v/v). The titled compound was obtained as yellow solid, m.p. 75–76 °C, Rf 0.29 (EtOAc/hexane, 1:3, v/v). Yield of 334 mg (1.06 mmol, 53%). 1H NMR (400 MHz, CDCl3) δ 8.33 (d, J = 13.3 Hz, 1H), 7.79 (d, J = 13.3 Hz, 1H), 7.73–7.66 (m, 1H), 7.55–7.49 (m, 1H), 7.37–7.27 (m, 2H), 5.53 (s, 2H), 3.52 (q, J = 7.0 Hz, 2H), 3.06–2.94 (m, 2H), 1.72–1.63 (m, 2H), 1.47–1.36 (m, 4H), 1.19 (t, J = 7.0 Hz, 3H), 0.93 (t, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 150.5, 138.0, 132.5, 132.0, 125.2, 123.7, 122.9, 120.3, 110.6, 106.7, 72.9, 64.5, 31.6, 30.5, 24.7, 22.4, 15.0, 14.0; FTIR, vmax: 3324, 3248, 2983, 1769, 1684, 1633, 1557, 1504, 1461, 1386, 1374, 1245 cm−1; HRMS (ESI TOF) m/z calc’d. for C18H24N2NaO3 [M+Na]+: 339.1679, found: 339.1672 (2.2 ppm).
(E)-2-Methyl-3-(2-nitrovinyl)-1-(prop-2-yn-1-yl)-1H-indole (10oa): This compound was prepared using Typical Procedure E employing (E)-2-methyl-3-(2′-nitrovinyl)indole (10aa) (1.01 g, 5 mmol), propargyl bromide (1.11 g, 0.8 mL 7.5 mmol, 80 wt. % in toluene) with the yield of 1.14 g (4.75 mmol, 95%). Purification was performed via recrystallization from ethanol. The titled compound was obtained as an orange solid, m.p. 105–106 °C (EtOH), Rf 0.64 (EtOAc/PE, 1:2, v/v). 1H NMR (400 MHz, DMSO-d6) δ 8.34 (d, J = 13.3 Hz, 1H), 7.97 (d, J = 13.2 Hz, 1H), 7.91 (d, J = 7.7 Hz, 1H), 7.67 (d, J = 8.0 Hz, 1H), 7.32 (t, J = 7.5 Hz, 1H), 7.27 (t, J = 7.4 Hz, 1H), 5.19 (s, 2H), 3.43 (s, 1H), 2.66 (s, 3H). 13C NMR (101 MHz, DMSO) δ 147.3, 136.8, 132.9, 131.0, 124.6, 123.2, 122.6, 120.5, 110.9, 105.7, 78.2, 75.7, 32.9, 10.5. IR, vmax: 3273, 2918, 1743, 1572, 1476, 1298, 1226, 1171, 1077 cm−1; HRMS (ESI TOF) m/z calcd. for C14H12N2NaO2 [M+Na]+: 263.0791, found: 263.0798 (−2.7 ppm).
(E)-2-benzyl-3-(2-nitrovinyl)-1-(prop-2-yn-1-yl)-1H-indole (10pa): This compound was prepared using Typical Procedure E employing (E)-2-benzyl-3-(2′-nitrovinyl)indole (10ai) (1.39 g, 5 mmol), propargyl bromide (1.11 g, 0.8 mL 7.5 mmol, 80 wt. % in toluene) with the yield of 1.26 g (4 mmol, 80%). Purification was performed via recrystallization from ethanol. The titled compound was obtained as an orange solid, m.p. 105–106 °C (EtOH), Rf 0.72 (EtOAc/PE, 1:2, v/v). 1H NMR (400 MHz, Chloroform-d) δ 8.41 (d, J = 13.3 Hz, 1H), 7.88 (d, J = 13.3 Hz, 1H), 7.84–7.80 (m, 1H), 7.48–7.44 (m, 1H), 7.40–7.36 (m, 2H), 7.34–7.27 (m, 3H), 7.12 (d, J = 7.0 Hz, 2H), 4.71 (d, J = 2.5 Hz, 2H), 4.45 (s, 2H), 2.29 (t, J = 2.5 Hz, 1H).13C NMR (101 MHz, CDCl3) δ 145.9, 137.3, 136.0, 132.9, 132.5, 129.3 (2C), 128.2 (2C), 127.5, 125.3, 124.1, 123.1, 120.8, 110.5, 107.9, 76.5, 73.9, 33.6, 30.5. IR, vmax: 3233, 2962, 1523, 1442, 1297, 1243, 1183, 1096 cm−1; HRMS (ESI TOF) m/z calcd. for C20H16N2NaO2 [M+Na]+: 339.1104, found: 339.1097 (2.1 ppm).
(E)-Ethyl 2-(2-methyl-3-(2-nitrovinyl)-1H-indol-1-yl)acetate (10qa): This compound was prepared using Typical Procedure E employing E-2-methyl-3-(2′-nitrovinyl)indole (10aa) (1.01 g, 5 mmol), ethyl 2-chloroacetate (915 mg, 7.5 mmol) with the yield of 1.037 g (3.6 mmol, 72%). The titled compound was purified using column chromatography (EtOAc/hexane, 1:1, v/v). The titled compound was obtained as yellow solid, m.p. 110–112 °C, Rf 0.25 (EtOAc/hexane, 1:1, v/v). 1H NMR (400 MHz, DMSO-d6) δ 8.36 (d, J = 13.2 Hz, 1H), 7.99 (d, J = 13.2 Hz, 1H), 7.95–7.87 (m, 1H), 7.60–7.53 (m, 1H), 7.31–7.23 (m, 2H), 5.27 (s, 2H), 4.17 (q, J = 7.1 Hz, 2H), 2.55 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H).13C NMR (101 MHz, DMSO) δ 168.2, 148.4, 137.7, 133.1, 130.9, 124.5, 123.2, 122.6, 120.4, 110.7, 105.6, 61.5, 45.0, 14.1, 10.5. IR, vmax: 3098, 2981, 2925, 2853, 1744, 1671, 1629, 1136, 1098, 1010, 910, 862 cm−1; HRMS (ESI TOF) m/z calcd. For C15H16N2NaO4 [M+Na]+: 311,1002, found: 311,1006 (−1.3 ppm).
3.2.6. Synthesis of (3R,4′S)-2-methyl-4′-phenyl-4′H-spiro[indole-3,5′-isoxazole]
The reaction vessel was charged with 2-methyl-1
H-indole (131 mg, 1.00 mmol), (2- nitrovinyl)benzene (164 mg, 1.10 mmol), phosphorous acid (1000 mg), and formic acid (1000 mg). The mixture was vigorously stirred for 2 h at 10 °C. The resulting dark-red homogeneous solution was poured into water (100 mL), and the formed precipitate was filtered and washed consecutively with water (four times). After drying, the resulting crystalline material was purified using flash column chromatography on silica gel, eluting with a mixture of hexane and ethyl acetate (4:1) [
34].
3.3. Synthesis of β-Carbolines Starting from 3-Nitrovinylindoles as Shown in Figure 7
β-Carboline (norharmane) (
12aa), Typical Procedure A (Method A) for preparation of β-carbolines (
12): (
E)-3-(2-nitrovinyl)-2-methyl-1
H-indole (
10aa) (202 mg, 1.00 mmol) and 2 mL of 1-butanol were charged in a G10 vial. The vial was sealed and heated in the microwave apparatus at 200 °C for 1 h. After completion of the reaction, the vial was opened, and the reaction mixture was concentrated in vacuo. Crude material was purified using column chromatography (benzene/ethanol, 9:1,
v/
v). The titled compound was obtained as colorless solid, m.p. 197–198 °C, lit [
43] m.p. 196–197 °C, R
f 0.43 (benzene/ethanol, 1:9,
v/
v). Yield of 82 mg (0.49 mmol, 49%).
1H NMR (400 MHz, CDCl
3) δ 8.93 (s, 1H), 8.54 (s, 1H), 8.48 (d,
J = 5.3 Hz, 1H), 8.15 (d,
J = 7.8 Hz, 1H), 7.98 (d,
J = 5.4 Hz, 1H), 7.60–7.51 (m, 2H), 7.31 (t,
J = 6.5 Hz, 1H);
13C{
1H} NMR (101 MHz, CDCl
3) δ 140.4, 139.4, 135.9, 133.8, 129.1, 128.7, 122.0, 121.6, 120.3, 114.9, 111.7; FTIR,
vmax: 3384, 2937, 2364, 2321, 1653, 1621, 1557, 1529, 1472, 1444, 1417 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
11H
9N
2 [M+H]
+: 169.0760, found: 169.0758 (1.4 ppm).
Typical Procedure B (Method B) for preparation of β-carbolines (12): (E)-3-(2-nitrovinyl)-2-methyl-1H-indole (10aa) (202 mg, 1.00 mmol) and 4 mL of chlorobenzene were charged in a G10 vial. Then, Boc2O (262 mg, 1.20 mmol) and dimethylaminopyridine (DMAP) (12 mg, 0.100 mmol) were added, and the resulting mixture was stirred at room temperature for 30 min. After this period of time, the resulting mixture was diluted with 1 mL of BuOH, and the vial was sealed and heated in the microwave oven at 200 °C for 1 h. After completion of the reaction, water (20 mL) was added, followed by extraction with EtOAc (4 × 20 mL). Combined organic phases were concentrated in vacuo. Crude material was purified using column chromatography (benzene/ethanol, 9:1, v/v). Yield of 116 mg (0.69 mmol, 69%). The obtained sample of 12aa was identical to that obtained using Typical Procedure A.
Preparation (Procedure F) of β-carboline 12aa from
tert-butyl (
E)-2-methyl-3-(2-nitrovinyl)-1H-indole-1-carboxylate (
13):
tert-butyl (
E)-2-methyl-3-(2-nitrovinyl)-1
H-indole-1-carboxylate (
15) [
33] (302 mg, 1.00 mmol) and 2 mL of 1-butanol were charged in a G10 vial. The vial was sealed and heated in the microwave apparatus at 200 °C for 1 h. After completion of the reaction, the vial was opened, and the reaction mixture was concentrated in vacuo. Crude material was purified using column chromatography (benzene/ethanol, 9:1,
v/
v). Yield of 133 mg (0.79 mmol, 79%). The obtained sample of norharmane (
12aa) was identical to that obtained using Typical Procedure A.
β-Carboline-2-oxide (
11aa): 3-(2-Nitrovinyl)-2-methylindole (
10aa) (1.00 mmol) and 20 mL of 1-butanol were charged in a G30 vial. The vial was sealed and heated in the microwave apparatus at 200 °C for 60 min. After completion of the reaction, the vial was opened, and the reaction mixture was evaporated to dryness. Crude material was purified using column chromatography (benzene/ethanol, 1:1,
v/
v), giving β-carboline-2-oxide (
11aa) in the yield of 64 mg (0.35 mmol, 35%), along with β-carboline (
12aa) in the yield of 17 mg (0.100 mmol, 10 mol%). The titled compound was obtained as colorless solid, m.p. 269–270 °C, lit [
44]. m.p. 238–240 °C, R
f 0.4 (benzene/ethanol, 1:1,
v/
v).
1H NMR (400 MHz, DMSO-
d6) 11.64 (s, 1H), 8.56 (s, 1H), 8.13 (dd,
J = 10.3, 7.3 Hz, 2H), 8.03 (dd,
J = 6.7, 1.4 Hz, 1H), 7.55 (d,
J = 8.2 Hz, 1H), 7.50–7.44 (m, 1H), 7.26–7.21 (m, 1H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 141.5, 137.1, 130.9, 127.4, 123.3, 121.1, 120.8, 120.2, 119.7, 116.9, 111.9; FTIR,
vmax: 3443, 3221, 1658, 1526, 1476, 1382, 1293, 1148 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
11H
8N
2NaO [M+Na]
+: 207.0529, found: 207.0527 (1.1 ppm).
Preparation (Procedure G) of β-carboline (12aa) from β-carboline-2-oxide (11aa): β-Carboline-2-oxide (11aa) (92 mg, 0.5 mmol) and 1 mL of 1-butanol were charged in a G10 vial. The vial was sealed and heated in the microwave apparatus at 200 °C for 60 min. After completion of the reaction, the vial was opened, and the reaction mixture was concentrated in vacuo. Crude material was purified using column chromatography (benzene/ethanol, 9:1, v/v). Yield of 56 mg (0.34 mmol, 67%). The obtained sample was identical to that obtained by Typical Procedure A.
6-Fluoro-β-carboline (
12ba): This compound was prepared using Method A employing (
E)-5-fluoro-2-methyl-3-(2-nitrovinyl)-1
H-indole (
10ba) (220 mg, 1.00 mmol) in the yield of 73 mg (0.39 mmol, 39%). Alternatively, this compound was prepared using Method B employing (
E)-5-fluoro-2-methyl-3-(2-nitrovinyl)-1
H-indole (
10ba) (220 mg, 1.00 mmol) in the yield of 99 mg (0.53 mmol, 53%). Purification was performed using column chromatography (EtOAc). The titled compound was obtained as white solid, m.p. 248.8–250.6 °C, lit [
45]. m.p. 254 °C, R
f 0.16 (EtOAc).
1H NMR (400 MHz, DMSO-
d6) δ 11.68 (s, 1H), 8.92 (s, 1H), 8.33 (d,
J = 5.3 Hz, 1H), 8.20–7.96 (m, 2H), 7.61 (dd,
J = 8.9, 4.4 Hz, 1H), 7.41 (td,
J = 9.2, 2.7 Hz, 1H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 156.6 (d,
J = 233.9 Hz), 138.0, 137.1, 137.0, 134.6, 127.2 (d,
J = 4.5 Hz), 121.0 (d,
J = 10.0 Hz), 116.4 (d,
J = 25.8 Hz), 115.1, 113.2 (d,
J = 9.2 Hz), 107.2 (d,
J = 23.6 Hz);
19F NMR (376 MHz, DMSO-
d6) δ -121.59; FTIR,
vmax: 3053, 2924, 2854, 1587, 1507, 1464, 1441, 1279, 1179, 1153 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
11H
8FN
2 [M+H]
+: 187.0666, found: 187.0666 (−0.1 ppm).
6-Bromo-β-carboline (eudistomin N) (
12ca): This compound was prepared using Method A employing (
E)-5-bromo-2-methyl-3-(2-nitrovinyl)-1
H-indole (
10ca) [
32] (280 mg, 1.00 mmol) in the yield of 86 mg (0.35 mmol, 35%). Alternatively, this compound was prepared using Method B employing (
E)-5-bromo-2- methyl-3-(2-nitrovinyl)- 1
H-indole (
10ca) [
35] (280 mg, 1.00 mmol) in the yield of 152 mg (0.62 mmol, 62%). Purification was performed using column chromatography (benzene/ethanol, 9:1,
v/
v). The titled compound was obtained as yellowish solid, m.p. 270–271 °C, lit [
43]. m.p. 266–268 °C, R
f 0.47 (benzene/ethanol, 1:9,
v/
v).
1H NMR (400 MHz, DMSO-
d6) δ 11.80 (s, 1H), 8.93 (d,
J = 1.0 Hz, 1H), 8.51 (d,
J = 2.1 Hz, 1H), 8.36 (d,
J = 5.3 Hz, 1H), 8.16 (d,
J = 5.3 Hz, 1H), 7.66 (dd,
J = 8.7, 2.1 Hz, 1H), 7.57 (d,
J = 8.7 Hz, 1H).;
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 139.2, 138.5, 136.3, 134.5, 130.6, 126.6, 124.5, 122.6, 115.1, 114.1, 111.3 FTIR,
vmax: 3122, 3063, 2738, 1867, 1721, 1684, 1656, 1630, 1558, 1540, 1487, 1434, 1273, 1243 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
11H
8BrN
2 [M+H]
+: 246.9865, found: 246.9862 (1.5 ppm).
6-Isopropyl-β-carboline (12da): This compound was prepared using Method A employing (E)-5-isopropyl-2-methyl-3-(2-nitrovinyl)-1H-indole (10da) (244 mg, 1.00 mmol) in the yield of 101 mg (0.48 mmol, 48%). Alternatively, this compound was prepared using Method B employing (E)-5-isopropyl-2-methyl- 3-(2-nitrovinyl)-1H-indole (10da) (244 mg, 1.00 mmol) in the yield of 139 mg (0.66 mmol, 66%). Purification was performed using column chromatography (EtOAc). The titled compound was obtained as colorless solid, m.p. 173.9–176.2 °C, Rf 0.18 (EtOAc). 1H NMR (400 MHz, DMSO-d6) δ 11.49 (s, 1H), 8.87 (s, 1H), 8.30 (d, J = 5.2 Hz, 1H), 8.11–8.05 (m, 2H), 7.51 (d, J = 8.4 Hz, 1H), 7.44 (dd, J = 8.5, 1.6 Hz, 1H), 3.14–2.98 (m, 1H), 1.31 (s, 3H), 1.29 (s, 3H); 13C{1H} NMR (101 MHz, DMSO) δ 139.6, 139.2, 137.9, 136.4, 134.0, 127.5, 127.3, 120.7, 118.6, 114.7, 111.8, 33.6, 24.6 (2C); FTIR, vmax: 3133, 3036, 2960, 1635, 1554, 1498, 1461, 1269, 1250 cm−1; HRMS (ESI TOF) m/z: calc’d for C14H15N2 [M+H]+: 211.1230, found 211.1228 (0.8 ppm).
6,7-Dimethyl-β-carboline (12ea): This compound was prepared using Method A employing (E)-2,5,6-trimethyl-3-(2-nitrovinyl)-1H-indole (10ea) (230 mg, 1.00 mmol) in the yield of 90 mg (0.46 mmol, 46%). Alternatively, this compound was prepared using Method B employing (E)-2,5,6-trimethyl-3-(2-nitrovinyl)- 1H-indole (10ea) (230 mg, 1.00 mmol) in the yield of 125 mg (0.64 mmol, 64%). Purification was performed using column chromatography (EtOAc). The titled compound was obtained as colorless solid, m.p. 263.2–264.8 °C, Rf 0.12 (EtOAc). 1H NMR (400 MHz, DMSO-d6) δ 11.39 (s, 1H), 8.82 (d, J = 1.0 Hz, 1H), 8.28 (d, J = 5.2 Hz, 1H), 7.99 (d, J = 5.2 Hz, 1H), 7.97 (s, 1H), 7.38 (s, 1H), 2.40 (s, 3H), 2.37 (s, 3H); 13C{1H} NMR (101 MHz, DMSO) δ 139.6, 137.9, 137.4, 136.1, 133.7, 127.7, 127.4, 121.7, 118.8, 114.3, 112.2, 20.62, 19.7; FTIR, vmax: 3053, 2924, 1638, 1553, 1452, 1317, 1262, 1246 cm−1; HRMS (ESI TOF) m/z: calc’d for C13H13N2 [M+H]+: 197.1073, found 197.1070 (1.9 ppm).
7,8-Dimethyl-β-carboline (12fa): This compound was prepared using Method A employing (E)-2,6,7-trimethyl-3-(2-nitrovinyl)-1H-indole (10fa) (230 mg, 1.00 mmol) in the yield of 92 mg (0.47 mmol, 47%). Alternatively, this compound was prepared using Method B employing (E)-2,6,7-trimethyl-3-(2-nitrovinyl)- 1H-indole (230 mg, 1.00 mmol) (10fa) in the yield of 125 mg (0.64 mmol, 64%). Purification was performed using column chromatography (EtOAc). The titled compound was obtained as colorless solid, m.p. 178.9–181.1 °C, Rf 0.14 (EtOAc). 1H NMR (400 MHz, Chloroform-d) δ 9.18 (s, 1H), 8.91 (s, 1H), 8.45 (d, J = 5.4 Hz, 1H), 8.08 (d, J = 5.4 Hz, 1H), 7.35 (d, J = 8.3 Hz, 1H), 7.26 (d, J = 8.2 Hz, 1H), 2.79 (s, 3H), 2.47 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 139.5, 138.7, 136.4, 133.5, 132.9, 130.9, 129.4, 127.7, 120.8, 117.0, 108.7, 19.5, 16.6; FTIR, vmax: 3123, 2924, 2854, 1648, 1623, 1504, 1457, 1327, 1300, 1277, 1149 cm−1; HRMS (ESI TOF) m/z: calc’d for C13H13N2 [M+H]+: 197.1073, found 197.1070 (1.5 ppm).
3-Methyl-β-carboline (
12ab): This compound was prepared using Method A employing (
E)-2-methyl-3-(2-nitroprop-1-en-1-yl)-1
H-indole (
10ab) (216 mg, 1.00 mmol) in the yield of 84 mg (0.46 mmol, 46%). Alternatively, this compound was prepared using Method B employing (
E)-2-methyl-3-(2-nitroprop-1-en-1-yl)-1
H- indole (
10ab) (216 mg, 1.00 mmol) in the yield of 116 mg (0.64 mmol, 64%). Purification was performed using column chromatography (benzene/ethanol, 9:1,
v/
v). The titled compound was obtained as colorless solid, m.p. 210–212 °C, lit [
46]. m.p. 208 °C, R
f 0.40 (benzene/ethanol, 1:9,
v/
v).
1H NMR (400 MHz, DMSO-
d6) δ 11.45 (s, 1H), 8.76 (s, 1H), 8.18 (d,
J = 7.8 Hz, 1H), 7.94 (s, 1H), 7.57–7.49 (m, 2H), 7.23–7.18 (m, 1H), 2.61 (s, 3H);
13C{
1H} NMR (101 MHz, DMSO-
d6) δ 146.2, 141.4, 134.8, 133.1, 129.1, 128.6, 122.2, 120.9, 119.5, 113.7, 112.3, 24.2; FTIR,
vmax: 3119, 2993, 1918, 1683, 1648, 1631, 1563, 1504, 1471, 1457, 1330, 1245 cm
−1; HRMS (ESI TOF)
m/
z calc’d. for C
12H
11N
2 [M+H]
+: 183.0917, found: 183.0915 (0.8 ppm).
3-Ethyl-β-carboline (12ac): This compound was prepared using Method A employing (E)-2-methyl-3-(2-nitrobut-1-en-1-yl)-1H-indole (10ac) (230 mg, 1.00 mmol) in the yield of 92 mg (0.47 mmol, 47%). Alternatively, this compound was prepared using Method B employing (E)-2-methyl-3-(2-nitrobut-1-en-1-yl)- 1H-indole (10ac) (230 mg, 1.00 mmol) in the yield of 127 mg (0.65 mmol, 65%). Purification was performed using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as colorless solid, m.p. 120–121 °C, Rf 0.27 (benzene/ethanol, 1:9, v/v). 1H NMR (400 MHz, CDCl3) δ 8.85 (s, 1H), 8.80 (s, 1H), 8.12 (d, J = 7.9 Hz, 1H), 7.83 (s, 1H), 7.65–7.38 (m, 2H), 7.36–7.12 (m, 1H), 3.03 (q, J = 7.6 Hz, 2H), 1.42 (t, J = 7.6 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 153.1, 141.1, 134.6, 132.7, 130.2, 128.5, 121.9, 121.6, 120.0, 112.5, 111.7, 31.3, 15.0; FTIR, vmax: 2957, 2930, 1734, 1703, 1686, 1563, 1623, 1558, 1504, 1471, 1452, 1439, 1343, 1245 cm−1; HRMS (ESI TOF) m/z calc’d. for C13H13N2 [M+H]+: 197.1073, found: 197.1069 (2.3 ppm).
1-Methyl-β-carboline (harmane) (
12ga): This compound was prepared using Method A employing (
E)-2-ethyl-3-(2-nitrovinyl)-1
H-indole (
10ga) (216 mg, 1.00 mmol) in the yield of 87 mg (0.48 mmol, 48%). Alternatively, this compound was prepared using Method B employing (
E)-2-ethyl-3-(2-nitrovinyl)-1
H-indole (
10ga) (216 mg, 1.00 mmol) in the yield of 120 mg (0.66 mmol, 66%). The titled compound was purified using column chromatography (benzene/ethanol, 9:1,
v/
v). The titled compound was obtained as colorless solid, m.p. 234–235 °C, lit [
43]. m.p. 235–236 °C, R
f 0.40 (benzene/ethanol, 1:9,
v/
v).
1H NMR (400 MHz, CDCl
3) δ 8.57 (s, 1H), 8.37 (d,
J = 5.4 Hz, 1H), 8.12 (d,
J = 7.9 Hz, 1H), 7.83 (d,
J = 5.4 Hz, 1H), 7.57–7.50 (m, 2H), 7.29 (ddd,
J = 8.1, 5.8, 2.4 Hz, 1H), 2.83 (s, 3H);
13C{
1H} NMR (101 MHz, CDCl
3) δ 141.9, 140.2, 138.8, 134.7, 128.5, 128.4, 122.2, 122.0, 120.3, 113.1, 111.7, 20.4; FTIR (film, NaCl, cm
−1): 3123, 2991, 1932, 1632, 1533, 1512, 1461, 1488, 1322, 1211, 1011 cm
−1; HRMS (ESI TOF)
m/
z Calc’d. for C
12H
11N
2 [M+H]
+: 183.0917, found: 183.0914 (1.3 ppm).
1-Butyl-β-carboline (12ha): This compound was prepared using Method A employing (E)-3-(2-nitrovinyl)-2-pentyl-1H-indole (10ha) (258 mg, 1.00 mmol) in the yield of 99 mg (0.44 mmol, 44%). Alternatively, this compound was prepared using Method B employing (E)-3-(2-nitrovinyl)-2-pentyl-1H-indole (10ha) (258 mg, 1.00 mmol) in the yield of 137 mg (0.61 mmol, 61%). Purification was performed using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as yellowish solid, m.p. 55–57 °C, Rf 0.53 (benzene/ethanol, 1:9, v/v). 1H NMR (400 MHz, CDCl3) δ 8.67 (s, 1H), 8.40 (d, J = 5.4 Hz, 1H), 8.12 (d, J = 7.8 Hz, 1H), 7.82 (d, J = 5.3 Hz, 1H), 7.56–7.50 (m, 2H), 7.31–7.26 (m, 1H), 3.12 (t, 2H), 1.92–1.84 (m, 2H), 1.49–1.39 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 146.1, 140.2, 138.8, 134.3, 128.7, 128.3, 122.8, 121.9, 120.2, 113.0, 111.7, 34.3, 31.0, 23.0, 14.1 FTIR, vmax: 3063, 2953, 2927, 2857, 1734, 1718, 1699, 1684, 1655, 1507, 1456, 1374, 1238 cm−1; HRMS (ESI TOF) m/z calc’d. for C15H17N2 [M+H]+: 225.1386, found: 225.1381 (2.3 ppm).
1-Phenyl-β-carboline (
12ia): This compound was prepared using Method A employing (
E)-2-benzyl-3-(2-nitrovinyl)-1
H-indole (
10ia) (278 mg, 1.00 mmol) in the yield of 120 mg (0.49 mmol, 49%). Alternatively, this compound was prepared using Method B employing (
E)-2-benzyl-3-(2-nitrovinyl)-1
H-indole (
10ia) (278 mg, 1.00 mmol) in the yield of 166 mg (0.68 mmol, 68%). Purification was performed using column chromatography (EtOAc/hexane, 1:2,
v/
v). The titled compound was obtained as colorless solid, m.p. 239.6–241.0 °C, lit [
43]. m.p. 242–244 °C, R
f 0.51 (EtOAc/hexane, 1:1).
1H NMR (400 MHz, DMSO-
d6) 11.53 (s, 1H), 8.46 (d,
J = 5.2 Hz, 1H), 8.27 (d,
J = 7.8 Hz, 1H), 8.12 (d,
J = 5.2 Hz, 1H), 8.08–8.00 (m, 2H), 7.67–7.50 (m, 5H), 7.26 (ddd,
J = 8.0, 7.0, 1.0 Hz, 1H);
13C{
1H} NMR (101 MHz, DMSO) δ 142.2, 141.1, 138.4, 138.4, 133.0, 129.2, 128.8 (2C), 128.6, 128.4 (2C), 128.2, 121.7, 120.9, 119.6, 114.0, 112.5; FTIR,
vmax: 2924, 2857, 1621, 1558, 1499, 1468, 1456, 1445, 1415, 1325 cm
−1; HRMS (ESI TOF)
m/
z: calc’d for C
17H
13N
2 [M+H]
+: 245.1073, found 245.1067 (2.4 ppm).
1-Butyl-6-chloro-7-methyl-β-carboline (12ja): This compound was prepared using Method A employing (E)-5-chloro-6-methyl-3-(2-nitrovinyl)-2-pentyl-1H-indole (10ja) (307 mg, 1.00 mmol) in the yield of 131 mg (0.48 mmol, 48%). Alternatively, this compound was prepared using Method B employing (E)-5-chloro-6-methyl-3-(2-nitrovinyl)-2-pentyl- 1H-indole (10ja) (307 mg, 1.00 mmol) in the yield of 185 mg (0.68 mmol, 68%). Purification was performed using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as yellowish solid, m.p. 181–182 °C, Rf 0.5 (benzene/ethanol, 1:9, v/v). 1H NMR (400 MHz, CDCl3) δ 8.48 (s, 1H), 8.38 (d, J = 5.4 Hz, 1H), 7.93 (s, 1H), 7.74 (d, J = 5.4 Hz, 1H), 7.52 (s, 1H), 3.08 (t, J = 7.9 Hz, 2H), 2.53 (s, 3H), 1.91–1.81 (m, 2H), 1.48–1.40 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 146.1, 139.1, 139.0, 134.8, 134.6, 128.2, 128.0, 123.1, 121.2, 112.8, 111.9, 34.1, 30.9, 23.0, 20.5, 14.1; FTIR, vmax: 2924, 2857, 1917, 1733, 1701, 1626, 1558, 1454, 1374, 1328, 1243 cm−1; HRMS (ESI TOF) m/z calc’d. for C16H18ClN2 [M+H]+: 273.1153, found: 273.1145 (3.0 ppm).
9-Methyl-β-carboline (12ka): This compound was prepared using Method A employing (E)-1,2-dimethyl-3-(2-nitrovinyl)-1H-indole (10ka) (216 mg, 1.00 mmol). Purification was performed using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as yellowish solid, m.p. 107–108 °C, Rf 0.47 (benzene/ethanol, 1:9, v/v). Yield of 84 mg (0.46 mmol, 46%). 1H NMR (400 MHz, CDCl3) δ 8.89 (s, 1H), 8.48 (d, J = 5.2 Hz, 1H), 8.15 (d, J = 7.8 Hz, 1H), 7.96 (dd, J = 5.2, 1.0 Hz, 1H), 7.62 (ddd, J = 8.3, 7.2, 1.1 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.33–7.27 (m, 1H), 3.95 (s, 3H).; 13C{1H} NMR (101 MHz, CDCl3) δ 141.8, 139.1, 137.1, 132.0, 128.5, 128.4, 122.0, 121.1, 119.7, 114.6, 109.4, 29.5; FTIR, vmax: 2930, 2851, 1771, 1718, 1701, 1686, 1626, 1557, 1500, 1474, 1451, 1328, 1248, 1151 cm−1; HRMS (ESI TOF) m/z calc’d. for C12H11N2 [M+H]+: 183.0917, found: 183.0914 (1.7 ppm).
9-Benzyl-β-carboline (12la): This compound was prepared using Method A employing (E)-1-benzyl-2-methyl-3-(2-nitrovinyl)-1H-indole (10la) (292 mg, 1.00 mmol). Purification was performed using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as colorless solid, m.p. 122–123 °C, Rf 0.53 (benzene/ethanol, 1:9, v/v). Yield of 103 mg (0.40 mmol, 40%). 1H NMR (400 MHz, CDCl3) δ 8.85 (s, 1H), 8.49 (d, J = 5.1 Hz, 1H), 8.18 (d, J = 7.7 Hz, 1H), 7.99 (dd, J = 5.3, 1.0 Hz, 1H), 7.57 (t, J = 7.1 Hz, 1H), 7.45 (d, J = 8.3 Hz, 1H), 7.34–7.25 (m, 4H), 7.15 (dd, J = 7.5, 2.1 Hz, 2H), 5.58 (s, 2H); 13C{1H} NMR (101 MHz, CDCl3) δ 141.5, 139.4, 136.8, 136.5 (2C), 132.5, 129.1 (2C), 128.7, 128.0, 126.6 (2C), 122.1, 121.4, 120.1, 114.7, 109.8, 47.0; FTIR, vmax: 2963, 2924, 1736, 1719, 1698, 1686, 1651, 1623, 1562, 1539, 1504, 1467, 1441, 1330, 1247 cm−1; HRMS (ESI TOF) m/z calc’d. for C18H15N2 [M+H]+: 259.1230, found: 259.1229 (0.1 ppm).
9-(Ethoxymethyl)-β-carboline (12ma): This compound was prepared using Method A employing (E)-1-(ethoxymethyl)-2-methyl-3-(2-nitrovinyl)-1H-indole (10ma) (260 mg, 1.00 mmol). The titled compound was purified using column chromatography (benzene/ ethanol, 9:1, v/v). The titled compound was obtained as yellowish solid, m.p. 79–80 °C, Rf 0.57 (benzene/ethanol, 1:9, v/v). Yield of 90 mg (0.4 mmol, 40%). 1H NMR (400 MHz, CDCl3) δ 9.02 (s, 1H), 8.51 (d, J = 5.3 Hz, 1H), 8.14 (d, J = 7.0 Hz, 1H), 7.96 (d, J = 5.3 Hz, 1H), 7.64–7.57 (m, 2H), 7.36–7.31 (m, 1H), 5.80 (s, 2H), 3.50 (q, J = 7.0 Hz, 2H), 1.16 (t, J = 7.0 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 141.4, 140.1, 136.8, 132.7, 129.2, 128.8, 122.0, 121.7, 120.7, 114.7, 110.2, 73.1, 64.5, 15.1; FTIR, vmax: 2960, 2871, 1734, 1714, 1684, 1651, 1626, 1562, 1510, 1489, 1474, 1462, 1376 cm−1; HRMS (ESI TOF) m/z calc’d. for C14H15N2O [M+H]+: 227.1179, found: 227.1178 (0.6 ppm).
3-Ethyl-9-methyl-β-carboline (12kc): This compound was prepared using Method A employing (E)-1,2-dimethyl-3-(2-nitrobut-1-en-1-yl)-1H-indole (10kc) (244 mg, 1.00 mmol). The titled compound was purified using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as colorless solid, m.p. 45–47 °C, Rf 0.47 (benzene/ethanol, 1:9, v/v). Yield of 63 mg (0.3 mmol, 30%). 1H NMR (400 MHz, CDCl3) δ 8.80 (s, 1H), 8.13 (d, J = 8.9 Hz, 1H), 7.83 (s, 1H), 7.60 (t, J = 7.8 Hz, 1H), 7.44 (d, J = 7.5 Hz, 1H), 7.29–7.27 (m, 1H), 3.93 (s, 3H), 3.02 (q, J = 7.6 Hz, 2H), 1.41 (t, J = 7.9 Hz, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 152.65, 142.30, 135.8, 130.8, 129.6, 128.4, 122.0, 121.1, 119.5, 112.4, 109.3, 31.2, 29.6, 15.1; FTFTIR, vmax: 2930, 2854, 1736, 1716, 1686, 1653, 1560, 1514, 1471, 1461, 1333, 1248 cm−1; HRMS (ESI TOF) m/z calc’d. for C14H15N2 [M+H]+: 211.1230, found: 211.1228 (0.8 ppm).
1-Butyl-9-(ethoxymethyl)-β-carboline (12na): This compound was prepared using Method A employing (E)-1-(ethoxymethyl)-3-(2-nitrovinyl)-2-pentyl1H-indole (10na) (316 mg, 1.00 mmol). The titled compound was purified using column chromatography (benzene/ethanol, 9:1, v/v). The titled compound was obtained as yellow oil, Rf 0.6 (benzene/ethanol, 1:9, v/v). Yield of 71 mg (0.25 mmol, 25%). 1H NMR (400 MHz, DMSO-d6) 8.33 (d, J = 5.1 Hz, 1H), 8.24 (d, J = 7.8 Hz, 1H), 8.01 (d, J = 5.1 Hz, 1H), 7.88 (d, J = 8.4 Hz, 1H), 7.61 (t, J = 7.7 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 5.88 (s, 2H), 3.51–3.45 (m, 2H), 3.31–3.26 (m, 2H), 1.85–1.74 (m, 2H), 1.48–1.42 (m, 2H), 1.06 (t, J = 7.0 Hz, 3H), 0.96 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (101 MHz, DMSO-d6) δ 146.7, 142.3, 139.3, 134.2, 129.8, 128.9, 122.0, 121.3, 120.8, 113.1, 111.0, 73.7, 63.5, 34.4, 31.6, 22.7, 15.4, 14.4; FTIR, vmax: 2969, 2831, 1719, 1684, 1651, 1514, 1451, 1328, 1248, 1151 cm−1; HRMS (ESI TOF) m/z calc’d. for C18H23N2O [M+H]+: 283.1805, found: 283.1813 (−2.7 ppm).
9-(Prop-2-yn-1-yl)-9
H-pyrido [3,4-b]indole (
12oa): This compound was prepared using Method A employing (
E)-2-methyl-3-(2-nitrovinyl)-1-(prop-2-yn-1-yl)-1
H-indole (
10oa) (240 mg, 1 mmol) with the yield of 82 mg (0.40 mmol, 40%). Purification was performed using column chromatography (EtOAc/hexane, 1:1,
v/
v). The titled compound was obtained as white solid, m.p. 120 °C (EtOH), lit [
47]. 113 °C, R
f 0.59 (EtOAc).
1H NMR (400 MHz, DMSO-
d6) δ 9.13 (s, 1H), 8.44 (d,
J = 5.2 Hz, 1H), 8.29 (d,
J = 7.8 Hz, 1H), 8.17 (d,
J = 5.2 Hz, 1H), 7.80 (d,
J = 8.3 Hz, 1H), 7.65 (t,
J = 7.7 Hz, 1H), 7.33 (t,
J = 7.4 Hz, 1H), 5.45 (d,
J = 2.4 Hz, 2H), 3.34 (t,
J = 2.4 Hz, 1H).
13C NMR (101 MHz, DMSO) δ 140.4, 139.0, 135.7, 132.8, 128.6, 128.0, 122.1, 120.8, 120.2, 114.8, 110.5, 78.8, 75.1, 32.2. IR,
vmax: 3296, 2925, 2857, 1621, 1558, 1499, 1468, 1456, 1445, 1415, 1325, 1211 cm
−1; HRMS (ESI TOF)
m/
z calcd. for C
14H
10N
2Na [M+Na]
+: 229.0736, found: 229.0731 (2.2 ppm).
1-Phenyl-9-(prop-2-yn-1-yl)-9H-pyrido[3,4-b]indole (12pa): This compound was prepared using Method A employing (E)-2-benzyl-3-(2-nitrovinyl)-1-(prop-2-yn-1-yl)-1H-indole (10pa) (316 mg, 1 mmol) with the yield of 116 mg (0.41 mmol, 41%). Purification using column chromatography (EtOAc/hexane, 1:1, v/v). The titled compound was obtained as a white solid, m.p. 151–152 °C (EtOH), Rf 0.81 (EtOAc). 1H NMR (400 MHz, chloroform-d) δ 8.56 (d, J = 5.2 Hz, 1H), 8.19 (d, J = 7.8 Hz, 1H), 7.99 (d, J = 5.2 Hz, 1H), 7.77–7.72 (m, 2H), 7.68–7.62 (m, 1H), 7.61–7.53 (m, 4H), 7.39–7.35 (m, 1H), 4.64 (d, J = 2.4 Hz, 2H), 2.22 (t, J = 2.4 Hz, 1H).13C NMR (101 MHz, CDCl3) δ 144.0, 142.3, 139.0, 134.0, 131.2, 129.5 (2C), 129.0, 129.0, 128.7 (2C), 121.9, 121.8, 120.9, 113.9, 111.9, 110.7, 78.1, 73.0, 35.0. IR, vmax: 3221, 2930, 2841, 1611, 1547, 1473, 1468, 1415, 1325, 1211 cm−1; HRMS (ESI TOF) m/z calcd. for C20H14N2Na [M+Na]+: 305.1049, found: 305.1055 (−2.0 ppm).
Ethyl 2-(9H-pyrido[3,4-b]indol-9-yl)acetate (12qa): This compound was prepared using Method A employing (E)-ethyl 2-(2-methyl-3-(2-nitrovinyl)-1H-indol-1-yl)acetate (10qa) (288 mg, 1.00 mmol), Purification was performed using column chromatography (EtOAc/hexane, 1:2, v/v, EtOAc). The titled compound was obtained as colorless oil, Rf 0.33 (EtOAc). Yield of 89 mg (0.35 mmol, 35%). 1H NMR (400 MHz, chloroform-d) δ 8.83 (s, 1H), 8.50 (d, J = 5.3 Hz, 1H), 8.16 (d, J = 7.8, 1.0 Hz, 1H), 7.98 (dd, J = 5.3, 1.1 Hz, 1H), 7.61 (m, 1H), 7.41 (dt, J = 8.3, 0.9 Hz, 1H), 7.33 (m, 1.0 Hz, 1H), 5.08 (s, 2H), 4.22 (q, J = 7.1 Hz, 2H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 168.0, 141.5, 139.6, 136.8, 131.7, 129.2, 128.9, 122.2, 121.5, 120.6, 114.9, 109.33, 62.1, 45.0, 14.3. IR, vmax: 2969, 2852, 1732, 1650, 1458, 1365, 1328, 1241, 1198, 1016 cm−1; HRMS (ESI TOF) m/z calcd. for C15H15N2O2 [M+H]+: 255.1128, found: 255.1133 (−2.0 ppm).
3.4. Synthesis of β-Carbolines with the Reaction of Indoles with 4-(2-Nitrovinyl)morpholine as Shown in Figure 8
9
H-Pyrido[3,4-
b]indole (12aa): Typical Procedure H (as shown in
Figure 8) involved employing 2-methyl-1H-indole (
14a) (131 mg, 1.00 mmol), 4-(2-nitrovinyl)morpholine (
15a) (316 mg, 2.00 mmol), 2,2,2-trichloroacetic acid (408 mg, 2.5 mmol) in 2 mL isoamyl alcohol. These starting materials and reagents were placed in a microwave reactor. The reactor was heated in the microwave apparatus at 70 °C for 0.5 h; then, the temperature was quickly raised to 200 °C, and the reaction mixture was kept at this temperature for additional 0.8 h. After completion of the reaction, the reaction mixture was removed from the microwave reactor and concentrated in vacuo. Crude material was purified using column chromatography (EtOAc/hexane, 1:3,
v/
v, EtOAc). The titled compound was obtained as light-yellow solid, m.p. 197–198 °C, R
f 0.56 (benzene/isopropanol, 1:1,
v/
v). Yield of 71 mg (0.42 mmol, 42%).
1H NMR (400 MHz, Chloroform-
d) δ 9.52 (br.s, 1H), 8.97 (s, 1H), 8.43 (d,
J = 5.4 Hz, 1H), 8.13 (d,
J = 7.9 Hz, 1H), 7.98 (d,
J = 5.3 Hz, 1H), 7.57–7.53 (m, 2H), 7.30 (m, 1H);
13C NMR (101 MHz, CDCl
3) δ 141.0, 138.0, 136.1, 133.1, 129.5, 129.0, 122.0, 121.3, 120.3, 115.1, 112.0; IR,
vmax: 3384, 2937, 2364, 2321, 1653, 1621, 1557, 1529, 1472, 1444, 1417 cm
−1; HRMS (ESI TOF)
m/
z calcd. for C
11H
9N
2 [M+H]
+: 169.0760, found: 169.0765 (−3.0 ppm).
6-Isopropyl-9H-pyrido[3,4-b]indole (12da): This compound was prepared using Typical Procedure H employing 5-isopropyl-2-methyl-1H-indole (14d) (173 mg, 1.00 mmol), 4-(2-nitrovinyl)morpholine (15a) (316 mg, 2.00 mmol), 2,2,2-trichloroacetic acid (408 mg, 2.5 mmol) in 2 mL isoamyl alcohol. Purification was performed using column chromatography (EtOAc/hexane, 1:1, v/v, EtOAc). The titled compound was obtained as brown solid, m.p. 172–175 °C, Rf 0.18 (EtOAc). Yield of 63 mg (0.30 mmol, 30%). 1H NMR (400 MHz, chloroform-d) δ 8.89 (s, 1H), 8.45 (d, J = 5.3 Hz, 1H), 8.29 (br.s, 1H), 7.98 (s, 1H), 7.96 (d, J = 5.3 Hz, 1H), 7.47–7.43 (m, 2H), 3.11 (m, 1H), 1.36 (d, J = 7.0 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 141.2, 139.2, 139.0, 136.3, 133.8, 129.1, 128.0, 121.7, 118.9, 114.8, 111.5, 34.3, 24.74 (2C). IR, vmax: 3133, 3036, 2960, 1635, 1554, 1498, 1461, 1269, 1250 cm−1; HRMS (ESI TOF) m/z calcd. for C14H15N2 [M+H]+: 211.1230, found: 211.1228 (1.0 ppm).
1-Phenyl-9H-pyrido[3,4-b]indole (12ia): This compound was prepared using Typical Procedure H employing 2-benzyl-1H-indole (14i) (207 mg, 1.00 mmol), 4-(2-nitrovinyl)morpholine (15a) (316 mg, 2.00 mmol), 2,2,2-trichloroacetic acid (408 mg, 2.5 mmol) in 2 mL isoamyl alcohol. Purification was performed using column chromatography (EtOAc/hexane, 1:2, v/v, EtOAc). The titled compound was obtained as light-yellow solid m.p. 240–242 °C, Rf 0.71 (EtOAc). Yield of 98 mg (0.40 mmol, 40%). 1H NMR (400 MHz, chloroform-d) δ 8.65 (br.s, 1H), 8.57 (d, J = 5.3 Hz, 1H), 8.17 (d, J = 7.9 Hz, 1H), 7.95 (dd, J = 6.4, 3.4 Hz, 3H), 7.56 (m, 3H), 7.51–7.47 (m, 2H), 7.32 (dd, J = 8.0, 6.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 143.1, 140.5, 139.6, 138.6, 133.6, 129.98, 129.35 (2C), 128.99, 128.67, 128.26, 121.99, 121.96, 120.4, 111.0, 111.7; IR, vmax: 924, 2857, 1621, 1558, 1499, 1456, 1445, 1415, 1325 cm−1; HRMS (ESI TOF) m/z calcd. for C17H13N2 [M+H]+: 245.1073, found 245.1067 (2.5 ppm).
9-Benzyl-6-methoxy-9H-pyrido[3,4-b]indole (12ra): This compound was prepared using Typical Procedure H employing 1-benzyl-5-methoxy-2-methyl-1H-indole (14r) (251 mg, 1.00 mmol), 4-(2-nitrovinyl)morpholine (15a) (316 mg, 2.00 mmol), 2,2,2-trichloroacetic acid (408 mg, 2.5 mmol) in 2 mL isoamyl alcohol. Purification was performed using column chromatography (EtOAc/hexane, 1:2, v/v, EtOAc). The titled compound was obtained as brown oil, Rf 0.38 (EtOAc). Yield of 90 mg (0.31 mmol, 31%). 1H NMR (400 MHz, CDCl3) δ 8.83 (br. s, 1H), 8.45 (d, J = 5.2 Hz, 1H), 7.95 (d, J = 5.3 Hz, 1H), 7.62 (d, J = 2.6 Hz, 1H), 7.35- (m, 1H), 7.27–7.30 (d, J = 3.3 Hz, 1H), 7.25–7.20 (m, 2H), 7.13 (dd, J = 6.2, 1.9 Hz, 2H), 5.56 (s, 2H), 3.94 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 154.3, 138.8, 137.2, 136.7, 136.5, 132.6, 129.1 (2C), 128.3, 127.9, 126.6 (2C), 121.6, 118.6, 114.7, 110.8, 104.0, 56.2, 47.2; IR, vmax: 2953, 2841, 1621, 1559, 1454, 1292, 1226, 1163 cm−1; HRMS (ESI TOF) m/z calcd. for C19H17N2O [M+H]+: 289.1335, found: 289.1332 (1.0 ppm).
6-Bromo-3-ethyl-9H-pyrido[3,4-b]indole (12cc): This compound was prepared using Typical Procedure H employing 5-bromo-2-methyl-1H-indole (14c) (210 mg, 1.00 mmol), 4-(2-nitrobut-1-en-1-yl)morpholine (15c) (372 mg, 2.00 mmol), 2,2,2-trichloroacetic acid (408 mg, 2.5 mmol) in 2 mL isoamyl alcohol. Purification was performed using column chromatography (EtOAc/hexane, 1:2, v/v, EtOAc). The titled compound was obtained as a light-yellow oil, Rf 0.2 (EtOAc). Yield of 75 mg (0.27 mmol, 27%). 1H NMR (400 MHz, CDCl3) δ 9.85 (br. S, 1H), 8.91 (s, 1H), 8.20 (d, J = 2.0 Hz, 1H), 7.76 (s, 1H), 7.59 (d, J = 9.0 Hz, 1H), 7.40 (d, J = 8.7 Hz, 1H), 3.03 (q, J = 7.7 Hz, 2H), 1.40 (t, J = 7.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 151.7, 140.3, 134.8, 131.9, 131.65, 130.1, 124.7, 122.8, 113.5, 113.0, 112.9, 30.3, 14.8; IR, vmax: 3143, 2961, 2848, 1646, 1489, 1447, 1276, 1111, 1049, 2026 cm−1; HRMS (ESI TOF) m/z calcd. For C13H12BrN2 [M+H]+: 275. 0179, found: 275. 0185 (−2.2 ppm).